Cullinan oncology to present at h.c. wainwright global investment conference

Cambridge, mass., may 19, 2022 (globe newswire) -- cullinan oncology, inc. (nasdaq: cgem) (“cullinan”) a biopharmaceutical company focused on developing a diversified pipeline of targeted therapies for patients with cancer, today announced that its chief financial officer, jeff trigilio, will present at the h.c. wainwright global investment conference, being held may 23-25 in miami, fl and virtually.
CGEM Ratings Summary
CGEM Quant Ranking